EUVIMEDOpdag EUVIMED
Crossref

Coagulation, fibrinolysis and platelet drop in patients undergoing transfemoral transcatheter aortic valve implantation

Taiga Katayama, Naoyuki Yokoyama iD, Yusuke Watanabe iD, Shuhei Koyama, Hideyuki Kawashima iD, Hirofumi Hioki, Ken Kozuma iD

Catheterization and Cardiovascular Interventions · 2024

DOI: 10.1002/ccd.31199 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, 2024. Written by Taiga Katayama and 6 co-authors. Institution: Department of Cardiology, Teikyo University School of Medicine, Tokyo, Japan. Major MEDLINE topics: Fibrinolysis, Blood Coagulation, Transcatheter Aortic Valve Replacement, Femoral Artery. Cited 2 times so far (Crossref); 17 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Transcatheter aortic valve implantation (TAVI) leads to transient platelet activation and hypercoagulation status, resulting in thrombocytopenia.

Aims

This study investigated the associations of coagulation/fibrinolysis status after transfemoral TAVI with valve type, post‐TAVI thrombocytopenia, and complication of TAVI.

Methods

Thrombin–antithrombin complex (TAT) and fibrin/fibrinogen degradation product (FDP) levels were measured before and 1 h, 1 day, and 2 days after TAVI. A percentage drop in platelet count (DPC) was determined from the pre‐ and lowest post‐procedural values.

Results

SAPIEN 3 (S3) was implanted in 158 patients and Evolut PRO/PRO+ (Evolut) in 117. Both TAT and FDP increased after TAVI. Pre‐TAVI balloon dilatation was generally performed on patients undergoing implantation with Evolut. Peak TAT was then stratified into 4 quartiles (Q1 to Q4). Of all 275 study patients, 69 patients reached ultra‐hypercoagulation status (Q4). S3, TAVI without pre‐balloon dilatation, DPC and bleeding complications were significantly associated with the ultra‐hypercoagulation status after TAVI. TAT was significantly greater 1 h after S3 implantation than Evolut (median [IQR], 43.1 [34.1–59.6] vs. 31.0 [25.0–40.4] ng/mL; p < 0.001). In contrast, FDP levels did not differ between the two at any measurement point. The difference in DPC among the peak TAT quartiles was statistically significant ( p < 0.001). The occurrence of bleeding complications was significantly higher in the group with ultra‐hypercoagulation status (5.8% vs. 1.0%, p = 0.036).

Conclusions

The increase in coagulation status and post‐TAVI thrombocytopenia were significantly greater after S3 implantation. Ultra‐hypercoagulation after TAVI was related to bleeding complications.

Subjects

MeSH terms (MEDLINE)

FibrinolysisBlood CoagulationTranscatheter Aortic Valve ReplacementFemoral ArteryBiomarkersAortic Valve StenosisThrombocytopeniaHumansFemaleMaleAged, 80 and overAgedTreatment OutcomeTime FactorsRisk FactorsPuncturesCatheterization, PeripheralPeptide HydrolasesAntithrombin IIIBlood PlateletsAortic ValveFibrin Fibrinogen Degradation ProductsHeart Valve ProsthesisProsthesis DesignBalloon ValvuloplastyPlatelet CountProspective Studies

Author keywords

coagulationfibrinolysis thrombocytopeniatranscatheter aortic valve implantation

Substances

Biomarkersantithrombin III-protease complexPeptide HydrolasesAntithrombin IIIFibrin Fibrinogen Degradation Productsfibrin fragment D

Authors and institutions

  • Department of Cardiology, Teikyo University School of Medicine, Tokyo, Japan.

ORCID profiles: Naoyuki Yokoyama, Yusuke Watanabe, Hideyuki Kawashima, Ken Kozuma

Cite

APA

Katayama, T., Yokoyama, N., Watanabe, Y., Koyama, S., Kawashima, H., Hioki, H., & Kozuma, K. (2024). Coagulation, fibrinolysis and platelet drop in patients undergoing transfemoral transcatheter aortic valve implantation. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31199

Vancouver

Katayama T, Yokoyama N, Watanabe Y, Koyama S, Kawashima H, Hioki H, et al. Coagulation, fibrinolysis and platelet drop in patients undergoing transfemoral transcatheter aortic valve implantation. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31199

BibTeX
@article{Katayama2024,
  author = {Katayama, Taiga and Yokoyama, Naoyuki and Watanabe, Yusuke and Koyama, Shuhei and Kawashima, Hideyuki and Hioki, Hirofumi and Kozuma, Ken},
  title = {Coagulation, fibrinolysis and platelet drop in patients undergoing transfemoral transcatheter aortic valve implantation},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2024},
  doi = {10.1002/ccd.31199}
}
Start for free →